Texas Bank & Trust Co Purchases New Shares in Danaher Co. (NYSE:DHR)

Texas Bank & Trust Co purchased a new stake in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 4,322 shares of the conglomerate’s stock, valued at approximately $992,000.

Several other hedge funds have also added to or reduced their stakes in DHR. Gilbert & Cook Inc. boosted its holdings in Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after buying an additional 42 shares during the last quarter. Grimes & Company Inc. boosted its holdings in Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after buying an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA boosted its holdings in Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after buying an additional 45 shares during the last quarter. Spinnaker Trust boosted its holdings in shares of Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after purchasing an additional 50 shares during the last quarter. Finally, Fortis Capital Advisors LLC boosted its holdings in shares of Danaher by 1.3% during the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock worth $914,000 after purchasing an additional 50 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 2.7%

Danaher stock opened at $196.03 on Friday. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The stock’s fifty day simple moving average is $196.87 and its 200-day simple moving average is $217.47. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $140.29 billion, a P/E ratio of 37.13, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, equities analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Insider Activity at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on DHR shares. StockNews.com upgraded Danaher from a “hold” rating to a “buy” rating in a report on Monday, May 12th. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. The Goldman Sachs Group decreased their price objective on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Finally, Wells Fargo & Company decreased their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $264.40.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.